Clinical Trial Update: Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old [Phase 1]

View source ↗

Summary

Phase 1 safety study of ACYW135 meningococcal polysaccharide vaccine in individuals aged 2-50 years has completed. The study was sponsored by Beijing Chaoyang D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• ACYW135 Meningococcal Polysaccharide Vaccine (ACYW135 meningococcal polysaccharide vaccine)

Snippet

Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention | Conditions: Meningococcal | Phase 1 | Status: COMPLETED